fig1

Figure 1. Graphical abstract illustrating the targets of interest described. mAB: Monoclonal antibody; TKI: tyrosine kinase inhibitor; msln: mesothelin; ADC: antibody-drug conjugate.

Figure 1. Graphical abstract illustrating the targets of interest described. mAB: Monoclonal antibody; TKI: tyrosine kinase inhibitor; msln: mesothelin; ADC: antibody-drug conjugate.
 
  
 All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/